We present the case of a patient with ventilator-associated pneumonia (VAP) caused by a pan-resistant Acinetobacter baumannii successfully treated with the combination colistin plus vancomycin plus rifampin, whose in vitro activity was investigated by checkerboard method and killing testing. Furthermore, the serum bactericidal activity (SBA) was assessed. Our case shows that an innovative regimen consisting of colistin plus antimicrobials active only against Gram-positive microorganisms might represent a valid therapeutic option for severe infections caused by colistin-resistant A. baumannii.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
colistin vancomycin
8
vancomycin rifampin
8
acinetobacter baumannii
8
ventilator-associated pneumonia
8
clinical vitro
4
vitro efficacy
4
efficacy colistin
4
rifampin colistin-resistant
4
colistin-resistant acinetobacter
4
baumannii causing
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!